Results 181 to 190 of about 1,027,177 (297)

Intellectual Capital Disclosure and Its Determinants: Empirical Evidence from Listed Pharmaceutical and Chemical Industry of Bangladesh

, 2019
Md. Musfiqur Rahman, Raihan Sobhan, Md. Shafiqul Islam   +2 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Social determinants of health and menopausal symptoms: path analysis using the WHO framework. [PDF]

BMC Public Health
Vakili F, Nasiri M, Jahanfar S, Shishehgar S, Mahmoodi Z, Hamzehgardeshi Z, Alamolhoda SH.   +6 more
europepmc   +1 more source

Insights into the Structural Determinants Required for High-Affinity Binding of Chiral Cyclopropane-Containing Ligands to α4β2-Nicotinic Acetylcholine Receptors: An Integrated Approach to Behaviorally Active Nicotinic Ligands

, 2012
Han-Kun Zhang, J. Brek Eaton, Li-Fang Yu, Mieke Nys, Angelica Mazzolari, René van Elk, August B. Smit, Vadim Alexandrov, Taleen Hanania, Emily Sabath, Allison Fedolak, Daniela Brunner, Ronald J. Lukas, Giulio Vistoli, Chris Ulens, Alan P. Kozikowski   +15 more
openalex   +2 more sources

Public antigenic determinant on a family of HLA-B molecules. [PDF]

, 1979
Benjamin D. Schwartz, Lisa K. Luehrman, Glenn E. Rodey   +2 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Determinants Associated With Pesticide Exposure in Patients With Head and Neck Cancer: Protocol for a Systematic Review.

JMIR Res Protoc
Sánchez-Ramírez GA, López Cabanillas Lomelí M, González-Martínez BE, Castro-Sánchez AE, De la Garza-Ramos MA, Cano-Verdugo G.   +5 more
europepmc   +1 more source

Determinants and implementation strategies to implement a reflection method for guideline-based informal caregiving in community nursing in the Netherlands: a mixed-method study. [PDF]

BMJ Open
Vullings N, Maas M, Adriaansen M, Vermeulen H, Van der Wees P, Heinen M.   +5 more
europepmc   +1 more source

The sigma 54 DNA‐binding domain includes a determinant of enhancer responsiveness [PDF]

, 1999
Matthew Chaney, Martin Buck
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source